000 | 02197 a2200577 4500 | ||
---|---|---|---|
005 | 20250514023920.0 | ||
264 | 0 | _c20020611 | |
008 | 200206s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.46.3.731-738.2002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaguire, Michael | |
245 | 0 | 0 |
_aEmergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cMar 2002 |
||
300 |
_a731-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aCarbamates |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFurans |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHIV Core Protein p24 _xdrug effects |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV Protease _xgenetics |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHIV Reverse Transcriptase _xantagonists & inhibitors |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 |
_aNucleosides _xpharmacology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aRNA, Viral _xchemistry |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
700 | 1 | _aShortino, Denise | |
700 | 1 | _aKlein, Astrid | |
700 | 1 | _aHarris, Wendy | |
700 | 1 | _aManohitharajah, Varsha | |
700 | 1 | _aTisdale, Margaret | |
700 | 1 | _aElston, Robert | |
700 | 1 | _aYeo, Jane | |
700 | 1 | _aRandall, Sharon | |
700 | 1 | _aXu, Fan | |
700 | 1 | _aParker, Hayley | |
700 | 1 | _aMay, Jackie | |
700 | 1 | _aSnowden, Wendy | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 46 _gno. 3 _gp. 731-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.46.3.731-738.2002 _zAvailable from publisher's website |
999 |
_c11758718 _d11758718 |